These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2948183)

  • 1. High-affinity fluorescent peptide binding to I-Ad in lipid membranes.
    Watts TH; McConnell HM
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9660-4. PubMed ID: 2948183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell-mediated association of peptide antigen and major histocompatibility complex protein detected by energy transfer in an evanescent wave-field.
    Watts TH; Gaub HE; McConnell HM
    Nature; 1986 Mar 13-19; 320(6058):179-81. PubMed ID: 2936964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of Ia and H-2Kk-bearing membranes to replace the antigen-presenting cell in an H-2Kk allogeneic cytotoxic T cell response.
    Weinberger O; Herrmann SH; Greenstein JL; Mescher MF; Burakoff SJ
    Eur J Immunol; 1985 Oct; 15(10):1013-8. PubMed ID: 2932336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
    Walden P; Nagy ZA; Klein J
    J Mol Cell Immunol; 1986; 2(4):191-7. PubMed ID: 2978228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic function of a cloned helper T cell line.
    Watanabe M; Yoshikawa M; Hozumi N
    Immunol Lett; 1987 Jun; 15(2):133-8. PubMed ID: 2957317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation by supported planar membranes containing affinity-purified I-Ad.
    Watts TH; Brian AA; Kappler JW; Marrack P; McConnell HM
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7564-8. PubMed ID: 6334313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between a "processed" ovalbumin peptide and Ia molecules.
    Buus S; Colon S; Smith C; Freed JH; Miles C; Grey HM
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3968-71. PubMed ID: 3487084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of antigen-presenting capacity to Ia-negative cells upon fusion with Ia-bearing liposomes.
    Coeshott C; Grey HM
    J Immunol; 1985 Mar; 134(3):1343-8. PubMed ID: 2981915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation by hapten-specific B lymphocytes. V. Requirements for activation of antigen-presenting B cells.
    Liano D; Abbas AK
    J Immunol; 1987 Oct; 139(8):2562-6. PubMed ID: 2958554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic competition at the level of peptide-Ia binding.
    Babbitt BP; Matsueda G; Haber E; Unanue ER; Allen PM
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4509-13. PubMed ID: 3459185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
    Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
    Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
    Whalen BJ; Tony HP; Parker DC
    J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable association of processed antigen with antigen-presenting cell membranes.
    Jensen PE
    J Immunol; 1989 Jul; 143(2):420-5. PubMed ID: 2786907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells.
    Harding CV; Collins DS; Slot JW; Geuze HJ; Unanue ER
    Cell; 1991 Jan; 64(2):393-401. PubMed ID: 1899049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell activation by preformed, long-lived Ia-peptide complexes. Quantitative aspects.
    Watts TH
    J Immunol; 1988 Dec; 141(11):3708-14. PubMed ID: 3141504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical association of CD4 and the T-cell receptor can be induced by anti-T-cell receptor antibodies.
    Rojo JM; Saizawa K; Janeway CA
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3311-5. PubMed ID: 2470100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T cell response with peptides is influenced by both peptide-binding specificity of major histocompatibility complex molecules and susceptibility of T cells to blocking.
    Lehmann PV; Cardinaux F; Appella E; Muller S; Falcioni F; Adorini L; Nagy ZA
    Eur J Immunol; 1989 Jun; 19(6):1071-7. PubMed ID: 2787751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self peptide requirement for class II major histocompatibility complex allorecognition.
    Demotz S; Sette A; Sakaguchi K; Buchner R; Appella E; Grey HM
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8730-4. PubMed ID: 1924332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by liposomes as model system for T-B cell interaction.
    Walden P
    Eur J Immunol; 1988 Nov; 18(11):1851-4. PubMed ID: 3264532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.